Understanding Signalling Pathways Mutated in Inherited Disorders
Understanding Signalling Pathways Mutated in Inherited Disorders
批准号:
MC_UU_00018/1
负责人:
Dario Alessi
金额:
$559.88万
依托单位:
依托单位国家:
英国
项目类别:
Intramural
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
我的实验室致力于解开一类重要的酶所扮演的角色,这些酶与人类疾病有关,控制着一种被称为“蛋白质磷酸化”的生物过程。许多疾病,包括帕金森病,癌症和高血压,都是由调节蛋白磷酸化的特定途径的改变引起的。我的研究计划将基于破译与帕金森病(LRRK2),癌症(SGK3途径)和高血压(WNK途径)相关的蛋白质磷酸化途径的分子细节。我们研究的首要目标是发现调节磷酸化的酶的破坏如何与人类疾病联系在一起。我们的目标是利用这些信息,并与临床医生以及制药公司合作,制定更好的策略,以更好地治疗和诊断疾病。
英文摘要
My laboratory focuses on unravelling the roles played by an important class of enzymes that are implicated in human disease, that control a biological process known as “protein phosphorylation”. Many diseases including Parkinson’s disease, cancer and high blood pressure, are caused by alterations in specific pathways that regulate protein phosphorylation. My research programme will be based on deciphering the molecular details of protein phosphorylation pathways that are associated with Parkinson’s Disease (LRRK2), cancer (SGK3 pathway) and hypertension (WNK pathway). The overarching goal of our research is to discover how disruptions in enzymes that regulate phosphorylation are linked to human disease. We aim to harness this information and work with clinicians as well as pharmaceutical companies to develop improved strategies to better treat and diagnose malady.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The New p.F1700L LRRK2 Variant Causes Parkinson's Disease by Extensively Increasing Kinase Activity.
新的 p.F1700L LRRK2 变体通过大幅增加激酶活性导致帕金森病。
DOI:
10.1002/mds.29385
发表时间:
2023
期刊:
official journal of the Movement Disorder Society
影响因子:
--
作者:
[Borsche M]
通讯作者:
Borsche M
DOI:
10.1021/acs.jmedchem.1c01532
发表时间:
2021-10-28
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Bond AG, Craigon C, Chan KH, Testa A, Karapetsas A, Fasimoye R, Macartney T, Blow JJ, Alessi DR, Ciulli A]
通讯作者:
Ciulli A
DOI:
10.1042/bcj20220019
发表时间:
2022-03-18
期刊:
The Biochemical journal
影响因子:
--
作者:
[]
通讯作者:
Staining of cells with GolgiTracker for Golgi flow cytometry analysis v1
使用 GolgiTracker 对细胞进行染色,进行高尔基流式细胞术分析 v1
DOI:
10.17504/protocols.io.e6nvwk1d2vmk/v1
发表时间:
2022
期刊:
影响因子:
--
作者:
[Bagnoli E]
通讯作者:
Bagnoli E
DOI:
10.1097/hjh.0000000000001554
发表时间:
2018-03
期刊:
Journal of hypertension
影响因子:
4.9
作者:
[Cervantes-Perez LG, Castaneda-Bueno M, Jimenez JV, Vazquez N, Rojas-Vega L, Alessi DR, Bobadilla NA, Gamba G]
通讯作者:
Gamba G
共 8 条
MRC Climate Crisis Network
-
批准号:MC_PC_21020
-
项目类别:Intramural
-
资助金额:$25.23万
-
财政年份:2022
-
负责人:Dario Alessi
-
依托单位:
Stratification of MRC funded scientific technologies and reagents for rapid and simple dissemination to the wider scientific community
-
批准号:MC_PC_20034
-
项目类别:Intramural
-
资助金额:$10.19万
-
财政年份:2021
-
负责人:Dario Alessi
-
依托单位:
Towards a unifying theory of Parkinson's disease: Investigation of the biochemical and genetic role of Rab GTPases
-
批准号:MR/P00704X/1
-
项目类别:Research Grant
-
资助金额:$30.68万
-
财政年份:2016
-
负责人:Dario Alessi
-
依托单位:
BBSRC Industrial CASE Partnership Grant
-
批准号:BB/I532253/1
-
项目类别:Training Grant
-
资助金额:$9.59万
-
财政年份:2010
-
负责人:Dario Alessi
-
依托单位:
Exploitation of mouse models to validate protein kinases as drug targets
-
批准号:MC_EX_G0802532
-
项目类别:Research Grant
-
资助金额:$49.18万
-
财政年份:2009
-
负责人:Dario Alessi
-
依托单位:
Characterisation of the LRRK2 protein kinase, mutated in inherited Parkinson s disease
-
批准号:G0700656/1
-
项目类别:Research Grant
-
资助金额:$32.38万
-
财政年份:2008
-
负责人:Dario Alessi
-
依托单位:
海外基金